Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.
T Yokoyama, … , P Hazarika, D L Mann
T Yokoyama, … , P Hazarika, D L Mann
Published November 1, 1993
Citation Information: J Clin Invest. 1993;92(5):2303-2312. https://doi.org/10.1172/JCI116834.
View: Text | PDF
Research Article Article has an altmetric score of 6

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.

  • Text
  • PDF
Abstract

To define the mechanism(s) responsible for the negative inotropic effects of tumor necrosis factor-alpha (TNF alpha) in the adult heart, we examined the functional effects of TNF alpha in the intact left ventricle and the isolated adult cardiac myocyte. Studies in both the ventricle and the isolated adult cardiac myocyte showed that TNF alpha exerted a concentration- and time-dependent negative inotropic effect that was fully reversible upon removal of this cytokine. Further, treatment with a neutralizing anti-TNF alpha antibody prevented the negative inotropic effects of TNF alpha in isolated myocytes. A cellular basis for the above findings was provided by studies which showed that treatment with TNF alpha resulted in decreased levels of peak intracellular calcium during the systolic contraction sequence; moreover, these findings did not appear to be secondary to alterations in the electrophysiological properties of the cardiac myocyte. Further studies showed that increased levels of nitric oxide, de novo protein synthesis, and metabolites of the arachidonic acid pathway were unlikely to be responsible for the TNF alpha-induced abnormalities in contractile function. Thus, these studies constitute the initial demonstration that the negative inotropic effects of TNF alpha are the direct result of alterations in intracellular calcium homeostasis in the adult cardiac myocyte.

Authors

T Yokoyama, L Vaca, R D Rossen, W Durante, P Hazarika, D L Mann

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1977 Total
Citations: 4 5 6 6 8 12 8 9 7 8 6 5 11 9 19 18 5 19 25 26 27 24 28 43 35 34 28 31 27 35 18 3 1 550
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2007 (25)

Title and authors Publication Year
NO-cGMP and TNF-α counter regulatory system in blood: Understanding the mechanisms leading to myocardial dysfunction and failure
M Elahi, S Asopa, B Matata
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2007
Mechanisms of sepsis-induced cardiac dysfunction
A Rudiger, M Singer
Critical Care Medicine 2007
Negative inotropic effects of tumour necrosis factor-αand interleukin-1βare ameliorated by alfentanil in rat ventricular myocytes
DJ Duncan, PM Hopkins, SM Harrison
British Journal of Pharmacology 2007
Recent advances of TNF-α antagonists in rheumatoid arthritis and chronic heart failure
SA Mousa, O Goncharuk, D Miller
Expert Opinion on Biological Therapy 2007
Cardiac remodeling and dysfunction in nephrotic syndrome
M Moreira-Rodrigues, R Roncon-Albuquerque, T Henriques-Coelho, AP Lourenço, B Sampaio-Maia, J Santos, M Pestana, AF Leite-Moreira
Kidney International 2007
The Effect of Cardiovascular Drugs on Pro-Inflammatory Cytokine Secretion and Natural Killer Activity of Peripheral Blood Mononuclear Cells of Patients with Chronic Heart Failure In vitro
AS ., YJ ., AE ., MK ., MM ., MS .
Pakistan Journal of Biological Sciences 2007
Levosimendan: A new option in acute septic cardiac failure?
BP Powell, BD Keulenaer
Emergency Medicine Australasia 2007
Effect of tumor necrosis factor α on electrically induced calcium transients elicited in C2C12 skeletal myotubes
LN van Kann, AJ Bakker
Muscle & Nerve 2007
Oral Administration of Candesartan Improves the Survival of Mice with Viral Myocarditis through Modification of Cardiac Adiponectin Expression
S Saegusa, Y Fei, T Takahashi, H Sumino, J Moriya, K Kawaura, J Yamakawa, T Itoh, S Morimoto, T Nakahashi, K Iwai, M Matsumoto, T Kanda
Cardiovascular Drugs and Therapy 2007
Levosimendan: Beyond its simple inotropic effect in heart failure
C Antoniades, D Tousoulis, N Koumallos, K Marinou, C Stefanadis
Pharmacology & Therapeutics 2007
Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy
D Westermann, S Linthout, S Dhayat, N Dhayat, A Schmidt, M Noutsias, XY Song, F Spillmann, A Riad, HP Schultheiss, C Tschöpe
Basic Research in Cardiology 2007
Does Nitric Oxide Contribute to Progressive Cardiac Tissue Damage and Dysfunction After Infarction?
C Berthonneche, MC Toufektsian, S Tanguy, C Ghezzi, JD Leiris, F Boucher
Antioxidants & Redox Signaling 2007
Thiazolidinediones as anti-inflammatory and anti-atherogenic agents
A Ceriello
Diabetes/Metabolism Research and Reviews 2007
The use of the tumour necrosis factor antagonist infliximab in heart transplant recipients: two case reports
S Metyas, D La, DG Arkfeld
Annals of the rheumatic diseases 2007
Tumor Necrosis Factor-α
E Heffler, M Berry, ID Pavord
BioDrugs 2007
Surgery for Myocardial Salvage in Acute Myocardial Infarction and Acute Coronary Syndromes
GM Comas, BC Esrig, MC Oz
Heart Failure Clinics 2007
Carvedilol, a nonselective β-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro
Y Mizuochi, K Okajima, N Harada, P Molor-Erdene, M Uchiba, H Komura, T Tsuda, H Katsuya
Translational Research 2007
Reduced-energy diet improves survival of obese KKAy mice with viral myocarditis: Induction of cardiac adiponectin expression
T Kanda, S Saegusa, T Takahashi, H Sumino, S Morimoto, T Nakahashi, K Iwai, M Matsumoto
International Journal of Cardiology 2007
Tumor necrosis factor-α alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes
SH Lee, YC Chen, YJ Chen, SL Chang, CT Tai, W Wongcharoen, HI Yeh, CI Lin, SA Chen
Life Sciences 2007
Cytokines in HIV-associated cardiomyopathy
JJ Monsuez, L Escaut, E Teicher, JC Charniot, D Vittecoq
International Journal of Cardiology 2007
Alteration of myocardial sarcoplasmic reticulum Ca 2+ -ATPase and Na + -Ca 2+ exchanger expression in human left ventricular volume overload
P Leszek, M Szperl, A Klisiewicz, J Janas, A Biederman, T Rywik, W Piotrowski, M Kopacz, J Korewicki
European Journal of Heart Failure 2007
Glucocorticoids Alter the Balance Between Pro- and Anti-inflammatory Mediators in the Myocardium in a Porcine Model of Brain Death
KM McLean, JY Duffy, PK Pandalai, JM Lyons, CF Bulcao, CJ Wagner, SA Akhter, JM Pearl
The Journal of Heart and Lung Transplantation 2007
Tumor necrosis factor-α is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction
Y Monden, T Kubota, T Inoue, T Tsutsumi, S Kawano, T Ide, H Tsutsui, K Sunagawa
American journal of physiology. Heart and circulatory physiology 2007
Caspase inhibition reduces cardiac myocyte dyshomeostasis and improves cardiac contractile function after major burn injury
DL Carlson, DL Maass, J White, P Sikes, JW Horton
Journal of applied physiology 2007
Cardiovascular Medicine
JT Willerson, HJ Wellens, JN Cohn, DR Holmes
2007

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 23 patents
Referenced in 1 clinical guideline sources
101 readers on Mendeley
See more details